从靶点发现到确定候选分子：这款全球创新小核酸药物迈出临床转化关键一步
AstraZeneca and Cholesgen Progress in Their Partnership to Promote Innovation in the Cardiovascular and Metabolic Diseases 阿斯利康与珂阑医药深化合作，共促心血管代谢疾病领域创新突破
珂阑医药获评国家高新技术企业
沪公网安备31011502401884